©The Author(s) 2022.
World J Gastroenterol. Dec 14, 2022; 28(46): 6497-6511
Published online Dec 14, 2022. doi: 10.3748/wjg.v28.i46.6497
Published online Dec 14, 2022. doi: 10.3748/wjg.v28.i46.6497
Table 3 Currently available colorectal cancer treatment methods
| Treatment methods | Types/medication details | Side-effects | Stages | Ref. |
| Surgery | Laparoscopic surgery | Pain; tenderness; irritation and itching; constipation or diarrhea | I, II, III, IV | [32,44] |
| Colostomy for rectal cancer | ||||
| Radiofrequency ablation or cryoablation | ||||
| Radiation therapy | External-beam radiation therapy | Fatigue; mild skin reactions; bleeding in stools; constipation or diarrhea; infertility | II, III, IV | [33,34] |
| Stereotactic radiation therapy | ||||
| Intraoperative radiation therapy | ||||
| Brachytherapy | ||||
| Chemotherapy | Capecitabine (Xeloda) | Vomiting; nausea; diarrhea; mouth sores; neuropathy; fatigue; hair loss | II, III, IV | [36,39] |
| Fluorouracil | ||||
| Irinotecan (Camptosar) | ||||
| Oxaliplatin (Eloxatin) | ||||
| Trifluridine/tipiracil (Lonsurf) | ||||
| Targeted therapy | Anti-angiogenesis therapy | Rashes | IV | [38,45] |
| Epidermal growth factor receptor inhibitors | ||||
| Combined targeted therapies | ||||
| Tumor-agnostic treatment | ||||
| Immunotherapy | Pembrolizumab (Keytruda) | Fatigue; rashes, pain and itching; diarrhea; nausea; fever; vomiting; shortness of breath | III, IV | [46,47] |
| Nivolumab (Opdivo) | ||||
| Dostarlimab (Jemperli) | ||||
| Nivolumab and ipilimumab (Yervoy) combination |
- Citation: Gogoi P, Kaur G, Singh NK. Nanotechnology for colorectal cancer detection and treatment. World J Gastroenterol 2022; 28(46): 6497-6511
- URL: https://www.wjgnet.com/1007-9327/full/v28/i46/6497.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i46.6497